Largest CIDP Trial Offers Promising Results for Drug Combo
Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.
United States Jeffreya Allen Brettm Morrison University Of Minnesota American Academy Of Neurology Johns Hopkins School Of Medicine
Source: medscape.com